Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 5/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.32 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.32 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.32 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5911151 | 0.81 | CHRM5 (0.46) | ALDH1A1MAPTCA1CA2CACNA1F | |
| SCHEMBL5911354 | 0.80 | CACNA1C (0.47) | ALDH1A1MAPTCACNA1FCACNA1DCACNA1S | |
| SCHEMBL5911402 | 0.78 | CA1 (0.40) | ALDH1A1MAPTCA1CA2KMT2A | |
| SCHEMBL5765323 | 0.78 | ALDH1A1 (0.40) | ALDH1A1MAPTCA1CA2CACNA1F | |
| SCHEMBL5911443 | 0.77 | CHRM5 (0.45) | ALDH1A1MAPTCA1CA2KMT2A | |
| SCHEMBL5767491 | 0.76 | CA1 (0.47) | ALDH1A1MAPTCA1CA2KMT2A | |
| SCHEMBL5764155 | 0.75 | CHRM5 (0.48) | ALDH1A1MAPTCA1CA2KMT2A | |
| SCHEMBL5911606 | 0.74 | CHRM5 (0.43) | ALDH1A1MAPTCA1CA2CACNA1F | |
| SCHEMBL5911596 | 0.74 | CHRM5 (0.43) | ALDH1A1CA1CA2KMT2ACHRM5 | |
| SCHEMBL5911255 | 0.73 | NPC1 (0.49) | ALDH1A1MAPTCA1CA2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | LG LIFE SCIENCES LTD. (KR) | 2006-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | HAVCR2, LIPC, FABP1 | ALDH1A1 1058/4885MAPT 3737/4885CA1 4060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.